Brexpiprazole Impurity 17
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

2250242-22-7Brexpiprazole Impurity 17

● In Stock

Catalogue No.:VE0012884
CAS No.:2250242-22-7
Mol. Formula:C28H34N4S2
Mol. Weight:490.74 g/mol

Additional information on CAS 2250242-22-7

Parent drug

Brexpiprazole

IUPAC Name

1, 4-bis(4-(benzo[b]thiophen-4-yl)piperazin-1-yl)butane

Pharmacopoeial Synonyms

N/A

Other Synonyms

N/A

Smiles

N1(C2=C3C=CSC3=CC=C2)CCN(CCCCN4CCN(C5=C6C=CSC6=CC=C5)CC4)CC1

Inchl

InChI=1S/C28H34N4S2/c1(11-29-13-17-31(18-14-29)25-5-3-7-27-23(25)9-21-33-27)2-12-30-15-19-32(20-16-30)26-6-4-8-28-24(26)10-22-34-28/h3-10,21-22H,1-2,11-20H2

Description

Brexpiprazole Impurity 17, also known as 1-(Benzothiophen-4-yl)-4-[4-[4-(benzothiophen-4-yl)piperazin-1-yl]butyl]piperazine, is a highly characterized reference material. It fully complies with stringent regulatory standards, including those set by USP, EMA, JP, and BP. This product is essential for use in Abbreviated New Drug Applications (ANDA), New Drug Applications (NDA), and the commercial production of Brexpiprazole. Moreover, it comes with a detailed Structure Elucidation Report (SER), ensuring its accuracy and reliability for a wide range of analytical applications.

Request a Quote

« * » indique les champs nécessaires

Ce champ n’est utilisé qu’à des fins de validation et devrait rester inchangé.
Products quotation
Name
Url